The optimal fluid treatment protocol for children with diabetic ketoacidosis (DKA) has long been a subject of controversy. Until recently, there was no high-quality evidence from randomized clinical trials to support an optimal guideline, and recommendations were mainly based on theo- DKA that occurred before arrival to the emergency department, before any intravenous fluids were administered. 13, 14 In addition, a large retrospective observational study conducted by our group found that associations between brain injuries and intravenous fluid infusion rates were no longer evident after adjusting for DKA severity and for laboratory markers of dehydration. 10 Subsequent studies by our group investigating physiological alterations in the brain during DKA also demonstrated
| HISTORICAL CONTEXT
Descriptions of cerebral edema with brain injury during treatment of diabetic ketoacidosis (DKA) in children appeared in the medical literature as early as the 1930s. [1] [2] [3] Children who experienced this complication frequently died, and autopsy reports documented cerebral edema in addition to findings suggesting hypoxic injury. In the 1980s, uncontrolled case series of children with DKA-related brain injuries noted that these children frequently received intravenous fluid infusions at higher rates than children who recovered from DKA without apparent complications. 4 It was therefore hypothesized that rapid infusions of intravenous fluids are responsible for brain injuries, with the most common hypothesis being that rapid intravenous fluid infusion results in declines in serum osmolality that cause fluid influx into the brain. 4, 5 Cerebral edema then occurs, causing increased intracranial pressure that results in brain injury. On the basis of this hypothesis, guidelines for treatment of DKA in children advocated either no fluid boluses or use of small fluid volumes for intravenous boluses at the beginning of treatment and avoidance of boluses whenever possible. Pediatric DKA guidelines also recommended replacement of fluid deficits using slow infusion rates and use of isotonic fluids in the first several hours or throughout treatment. [6] [7] [8] These guidelines have been followed at most pediatric centers; however, declines in the frequency of DKA-related brain injuries have not been observed. [9] [10] [11] [12] In addition to the lack of apparent decrease in the rate of DKArelated brain injuries with use of guidelines recommending slow rates of intravenous fluid infusion, several other epidemiological features of DKA-related brain injury have become apparent over time. First, there have been case reports describing severe brain injuries in children with DKA that occurred before arrival to the emergency department, before any intravenous fluids were administered. 13, 14 In addition, a large retrospective observational study conducted by our group found that associations between brain injuries and intravenous fluid infusion rates were no longer evident after adjusting for DKA severity and for laboratory markers of dehydration. 10 Subsequent studies by our group investigating physiological alterations in the brain during DKA also demonstrated characteristics that are inconsistent with osmotically mediated cell swell- DKA episodes in 1255 children were randomized to one of four fluid treatment arms using a two-by-two factorial study design. 23, 24 Two arms used more rapid fluid infusion and assumed a fluid deficit of 10% of body weight. (Table 1 ) The other two arms used slower fluid infusion and assumed an estimated 5% fluid deficit. Within the fast or slow infusion arms of the study, half of the patients received fluid replacement using 0.9% NaCl solution and the other half using 0.45% NaCl. Mental status was assessed in study participants using hourly Glasgow Coma Scale (GCS) scores. We used tests of short-term memory (digit span recall) to detect more subtle alterations in cognitive function during DKA treatment. Records of patients who were treated with mannitol or 3% saline, or who were intubated or died during treatment, were reviewed by an independent adjudication committee of three experts masked to the study arm to determine whether these patients met published criteria for DKA-related brain injury. 25 Study participants returned 3 to 6 months after recovery from DKA to undergo comprehensive memory testing and testing of intelligence quotient.
The PECARN FLUID Trial found no significant differences between study arms in either mental status changes (assessed by GCS and digit span scores) during DKA treatment, clinical diagnoses of brain injury, or cognitive testing scores at follow-up. 24 Clinically apparent brain injury occurred in 0.9% of study participants, similar to rates observed previously in children with DKA. 10, 26, 27 Of note, the lowest frequencies of GCS score decline during treatment and of clinical diagnoses of brain injury were observed in the rapid fluid infusion arms, although these differences were not statistically significant. In subanalyses involving children with more severe DKA (those with pH or pCO2 values in the lowest quartiles of the study population), shortterm memory scores improved more rapidly during DKA treatment in the fast fluid infusion arms. There were no differences in the frequencies of severe adverse events among study arms. Higher rates of hyperchloremic acidosis were associated with use of 0.9% NaCl solution and with more rapid fluid infusion; however, the time to DKA resolution and length of hospital stay did not differ between rapid vs slow fluid infusion and 0.9% NaCl vs 0.45% NaCl solutions.
| FLUID trial limitations
The FLUID Trial is the first source of high-quality evidence from a prospective randomized controlled trial on which to base fluid treatment guidelines for children with DKA; however, the study data also have some limitations. Children presenting with severe neurological abnormalities (GCS scores of 11 or lower) were excluded from the trial after the second year because clinicians felt that treatment in these patients should not be randomized, and these children had already met the study outcome (abnormal GCS scores suggesting cerebral 23 . Reprinted with permission.
injury) at presentation. However, 28 patients with mild to moderate abnormalities in mental status (GCS scores <14) at presentation were enrolled. Analyses of this small subgroup showed similar rates of improvement in GCS scores in all study arms; however, statistical power to detect differences in this group was limited. In addition, although there was a substantive difference in fluid infusion rates between the fast and slow arms used in the study, both rates were within the range currently used in protocols across the United States.
It is therefore unclear whether fluid infusion rates above or below the ranges used in the study may be beneficial or harmful. Similarly, whether use of fluid electrolyte content other than 0.45% or 0.9% NaCl (eg, use of balanced electrolyte solutions) might impact neurological outcomes was not studied.
| Understanding the FLUID trial results in the context of previous retrospective data
The finding that rates of fluid infusion and fluid electrolyte content do not substantially influence the risk of brain injury in children with DKA may initially appear counterintuitive, given previous retrospective data. 4, 28, 29 In these retrospective studies, however, treatments were, by definition, non-randomized, and there was no adjustment for severity of illness and other important factors. Without randomization of treatment assignment, rigorously controlling for factors that may influence study outcomes is essential. Severity of acidosis and dehydration are risk factors for DKA-related brain injury, 10 several well-controlled studies. 10, 27, 30 Data from rodent models demonstrate that DKA is associated with reduced cerebral blood flow, and imaging studies in children with DKA document hyperemia and vasogenic edema after several hours of DKA treatment, consistent with ischemia/reperfusion injury. 16, 17, 31, 32 In addition to abnormalities in cerebral perfusion, substantial evidence indicates that a hyperinflammatory state occurs during DKA. Elevated levels of inflammatory mediators during DKA have been documented in both human and animal studies, [33] [34] [35] [36] [37] [38] and findings in studies by our group document patterns of inflammation consistent with those observed in ischemia/ reperfusion injury. 39 Finally, accumulating data suggest that the brain is not the only organ that is frequently injured during DKA. A recent study documented acute kidney injury (AKI) in 64% of children with DKA. 40 Stage 2 or 3 AKI occurred in more than half of these children, indicating renal injury beyond simply prerenal azotemia. The occurrence of injuries to multiple organs, abnormal organ perfusion, and hyperinflammation suggests a pattern typical of multiple organ dysfunction syndrome. 41, 42 Whether DKA-related brain injury might involve similar pathophysiology should be further investigated.
| Implications of the FLUID trial results for clinical care
Findings from the FLUID Trial provide evidence that rapid fluid infu- Fluid deficit estimation Assume 5% to 10% fluid deficit (~7% is appropriate for most children). [43] [44] [45] Replacement of deficit Replace estimated fluid deficit over 24 to 36 h. Fluids with NaCl content between 0.45% and 0.9% are acceptable.
Monitoring and adjustment of fluid treatment regimen b
Monitor HR, peripheral perfusion, intake, and output.
• Increase fluid infusion rate if HR and peripheral perfusion are not improving or worsen during treatment.
• Adjust fluid treatment based on intake and output (I/O) balance such that the estimated deficit will be replaced by 24 to 36 h.
Abbreviation: DKA, diabetic ketoacidosis; NaCl, sodium chloride. a Note that these guidelines pertain to fluid infusion rates and NaCl content of fluids only. Potassium replacement, insulin treatment, and other aspects of DKA therapy should follow previously published guidelines. 46 b Blood pressure is not a good indicator of circulatory status in children with DKA and should not be used as a parameter for monitoring hydration status. 47 
